ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
Treviso, Veneto, Italy
Local medical services in Treviso
Piazzale dell'Ospedale, 1, 31100 Treviso TV
About ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
During the past decade, ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2013-11-15
2018-03-27
Completed
240
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)
2014-04-30
2016-06-10
Completed
172
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
2017-10-25
2022-04-07
Completed
619
A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
2019-08-12
2023-07-12
Active, not recruiting
155
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
According to Clinical.Site data, the most researched conditions in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are
"Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" in a lesser frequency.
Clinical Trials Intervention Types at ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
Most popular intervention types in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
The vast majority of trials in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are
4 trials for "All" genders.
Clinical Trials Status at ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso
Currently, there are NaN active trials in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".